Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.83x is 84% above its 1-year average of -5.32x, near the high end of its 1-year range (-14.97x–-0.83x).
As of the fiscal period ended Monday, March 31, 2025. 84.34% above its 12-month average of -5.32x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2025 (2025-03-31): -0.83x.
INTEREST COVERAGE RATIO
-0.83x
INTEREST COVERAGE RATIO AVG TTM
-5.32x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+84.34%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+86.95%
vs the sector median at left
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Interest Coverage Ratio
-0.83x
TTM Avg
-5.32x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.05M
Interest Coverage Ratio
-129.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.86M
Interest Coverage Ratio
-54.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.42M
Interest Coverage Ratio
-219.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | -0.83x | -5.32x | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.13M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.10M | -57.26x | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | -129.91x | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.01M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.41M | -1.99x | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -54.10x | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.82M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.42M | -219.72x | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | -19.65x | N/A | N/A | N/A |
Interest Coverage
-0.8x
Debt/Equity
0.02
Current Ratio
1.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-03-31 | -0.83x |
| 2024-12-31 | -4.12x |
| 2024-09-30 | -2.90x |
| 2024-06-30 | -3.76x |
| 2024-03-31 | -14.97x |
